Levi A. Garraway

Levi Garraway is a leader in cancer genomics and precision oncology who has made fundamental discoveries in melanoma genetics and cancer drug resistance. As CMO at Genentech, he leads global drug development programs. Garraway's academic work identified BRAF mutations in melanoma and characterized mechanisms of targeted therapy resistance.

Levi Garraway是癌症基因组学和精准肿瘤学的领导者，在黑色素瘤遗传学和癌症药物耐药性方面做出了基础性发现。作为基因泰克的CMO，他领导全球药物开发项目。Garraway的学术工作鉴定了黑色素瘤中的BRAF突变并描述了靶向治疗耐药机制。